<?xml version="1.0" encoding="UTF-8"?>
<p>A systematic review of observational studies of corticosteroids administered to patients with SARS-CoV-1 reported no survival benefit and possible harm and increased mortality and secondary infections were noted with severe influenza A; however, the evidence quality was low.(
 <xref rid="R43" ref-type="bibr">43</xref>) A subsequent study noted in the WHO guidelines found no effect on mortality.(
 <xref rid="R43" ref-type="bibr">43</xref>) Similarly in patients with MERS-CoV, corticosteroids had no effect on mortality but a delayed lower respiratory tract clearance of virus.(
 <xref rid="R43" ref-type="bibr">43</xref>)
</p>
